Newsletter Archives

Newsletter
27.05.2021

Leverage the power of CMC in early drug development

Read more
Prevent undesired immunogenicity from becoming the barrier for innovative biotherapeutics featured image

Newsletter
12.04.2021

Prevent undesired immunogenicity from becoming the barrier for innovative biotherapeutics

Read more
Discriminatory dissolution test method in late development featured image

Newsletter
04.03.2021

Discriminatory dissolution test method in late development

Read more
Scientific Advice and Dialogue with EMA during Drug Development featured image

Newsletter
28.09.2020

Scientific Advice and Dialogue with EMA during Drug Development

Read more
Oligonucleotide therapeutics: How to measure plasma concentration, tissue distribution and immunogenicity? featured image

Newsletter
31.07.2020

Oligonucleotide therapeutics: How to measure plasma concentration, tissue distribution and immunogenicity?

Read more

Newsletter
29.05.2020

Powder blending in early-phase drug product development: Balancing art and science

Read more